Management of Chronic Heart Failure Guided by Individual N-Terminal Pro-B-Type Natriuretic Peptide Targets Results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) Study

Autor: Eurlings, Luc W.M., van Pol, Petra E.J., Kok, Wouter E., van Wijk, Sandra, Lodewijks-van der Bolt, Cara, Balk, Aggie H.M.M., Lok, Dirk J.A., Crijns, Harry J.G.M., van Kraaij, Dave J.W., de Jonge, Nicolaas, Meeder, Joan G., Prins, Martin, Pinto, Yigal M.

Publikováno v: Journal of the American College of Cardiology, 56(25), 2090-2100. Elsevier USA
Journal of the American College of Cardiology, 56(25), 2090-2100. Elsevier Science

Objectives The purpose of this study was to assess whether management of heart failure (HF) guided by an individualized N-terminal pro-B-type natriuretic peptide (NT-proBNP) target would lead to improved outcome compared with HF management guided by

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7fd6561b731903cde5a7122e41c04ff1
https://pure.amc.nl/en/publications/management-of-chronic-heart-failure-guided-by-individual-nterminal-probtype-natriuretic-peptide-targets-results-of-the-prima-can-probrainnatriuretic-peptide-guided-therapy-of-chronic-heart-failure-improve-heart-failure-morbidity-and-mortality-study(422c2221-f835-4ee5-9c2b-825a08ea417d).html